Vimarsana
Biggest News Aggregation in the World

Page 22 - Hal Barron News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hal Barron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hal Barron Today - Breaking & Trending Today

GlaxoSmithKline appoints Tony Wood as chief scientific officer designate | 19 January 2022 - Vimarsana News

GlaxoSmithKline appoints Tony Wood as chief scientific officer designate | 19 January 2022

GlaxoSmithKline appoints Tony Wood as chief scientific officer designate

Altos Labs launches with the goal to transform medicine through cellular rejuvenation programming - Vimarsana News

Altos Labs launches with the goal to transform medicine through cellular rejuvenation programming

/PRNewswire/ -- Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation...

Altos Labs launches with the goal to transform medicine through cellular rejuvenation programming - Vimarsana News

Altos Labs launches with the goal to transform medicine through cellular rejuvenation programming

/PRNewswire/ -- Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation...

GlaxoSmithKline appoints Tony Wood as CSO Designate - DirectorsTalk Interviews - Vimarsana News

GlaxoSmithKline appoints Tony Wood as CSO Designate - DirectorsTalk Interviews

GlaxoSmithKline appoints Tony Wood as CSO Designate

Altos Labs Launches with $3B and a Focus on Reversing Disease, Aging - Vimarsana News

Altos Labs Launches with $3B and a Focus on Reversing Disease, Aging

With $3 billion in capital and an executive team to be led by Hal Barron, MD, until now GlaxoSmithKline (GSK)’s President of R&D and Chief Scientific Officer, Altos Labs™ today emerged from stealth mode, launching as an anti-aging startup with the ambitious aim of reversing disease, injury, and disabilities through cellular rejuvenation programming.